Clinical Trial Update: Immunoprevention for High-risk Lung Lesions [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial on immunoprevention for high-risk lung nodules is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Nodules

Snippet

Sponsor: Robert Samstein | Conditions: High-risk Lung Nodules | Phase 2 | Status: RECRUITING